Generated by All in One SEO v5.0.0.1, this is an llms.txt file, used by LLMs to index the site.

# M.H. Mohseni Institute of Urologic Sciences

Transforming Urologic Care Through Innovation

## Sitemaps

- [XML Sitemap](https://mius.ca/sitemap.xml): Contains all public & indexable URLs for this website.

## Posts

- [News](https://mius.ca/news/) - Stay updated on the latest breakthroughs in urologic research, innovative treatments, and expert insights from the M.H. Mohseni Institute of Urologic Science.
- [Could a blood test detect cancer recurrence in patients who have undergone orchiectomy?](https://mius.ca/could-a-blood-test-detect-cancer-recurrence-in-patients-who-have-undergone-orchiectomy/) - A simple miR371 blood test may help detect cancer relapse earlier in patients with early-stage germ cell tumors after orchiectomy.
- [From Bench to Bladder: Q&A with Urologic Sciences Faculty Member Dr. Morgan Roberts](https://mius.ca/from-bench-to-bladder-qa-with-urologic-sciences-faculty-member-dr-morgan-roberts/) - A newly published Q&A highlights the research journey of Dr. Morgan Roberts, who completed her PhD in the Department of Microbiology and Immunology at the University of British Columbia and is now an Assistant Professor in the Department of Urologic Sciences at UBC. The feature explores Dr. Roberts’ path through academic research and the experiences
- [Integrating Molecular Insight into Bladder Cancer Care: A New Classifier for Early Low-Grade Tumors](https://mius.ca/integrating-molecular-insight-into-bladder-cancer-care-a-new-classifier-for-early-low-grade-tumors/) - Bladder cancer is a biologically heterogeneous disease, and even tumors classified as early-stage and low-grade can harbor molecular features that may predispose them to recurrence. While clinical tools, including the IBCG risk criteria, provide a valuable framework for decision-making, they cannot fully resolve the underlying biological complexity of these tumors. In a new study published in European Urology Oncology, Dr.
- [VPC Researchers Publish New Findings on Clonal Hematopoiesis Following Radioligand Therapy](https://mius.ca/vpc-researchers-publish-new-findings-on-clonal-hematopoiesis-following-radioligand-therapy/) - Dr. Alex Wyatt and his research team at the Vancouver Prostate Centre have published a new paper in Clinical Cancer Research exploring hematologic changes following radioligand therapy (RLT) in metastatic prostate cancer. The work was led by PhD student Asli Munzur, who presented the initial findings at ASCO 2025. The study reports an increase in clonal hematopoiesis
- [Vancouver Prostate Centre Researchers Lead Development of Gemini, a Novel Self-Amplifying Vaccine and Nanomedicine Platform](https://mius.ca/vancouver-prostate-centre-researchers-lead-development-of-gemini-a-novel-self-amplifying-vaccine-and-nanomedicine-platform/) - Researchers at the Vancouver Prostate Centre have developed Gemini, a novel self-amplifying nucleic acid platform designed to address key limitations of current mRNA technologies. The research, led by Professor Wilfred A. Jefferies, was recently published in Nature Communications. Gemini is a binary self-amplifying expression system that can function as either self-amplifying RNA (saRNA) or self-amplifying DNA (saDNA). In both
- [Advancing Precision Approaches for Severe Bladder Cancer](https://mius.ca/advancing-precision-approaches-for-severe-bladder-cancer/) - Peter Black, Director of the Vancouver Prostate Centre, is leading research that applies advanced proteomic profiling to improve understanding of severe bladder cancers; an area of significant unmet clinical need. Bladder cancer is a biologically complex disease, particularly in its more aggressive forms, where patient outcomes can vary widely. Traditional diagnostic and treatment approaches often Peter Black, Director of the Vancouver Prostate Centre, is leading research that applies advanced proteomic profiling to improve understanding of severe bladder cancers; an area of significant unmet clinical need. Bladder cancer is a biologically complex disease, particularly in its more aggressive forms, where patient outcomes can vary widely. Traditional diagnostic and treatment approaches often
- [Recipients of the 2025 Terry Fox New Frontiers Program Project Grants (PPGs)](https://mius.ca/recipients-of-the-2025-terry-fox-new-frontiers-program-project-grants-ppgs/) - We’re thrilled to announce $14.5 million in new funding through the 2025 Terry Fox New Frontiers Program Project Grants (PPGs), supporting cutting-edge research in sarcomas, bladder cancer, high-risk brain cancer and immunotherapies. These multi-institutional teams are pushing the boundaries of cancer research: Dr. Michele Ardolino’s (Ottawa Hospital Research Institute) team will explore why some patients don’t respond to immunotherapy and how the entire body can be empowered to eliminate cancer through more personalized, targeted therapies. Dr. Peter Black (Vancouver Prostate Centre, University
- [DNA-guided platform paves way for more precise cancer treatments](https://mius.ca/dna-guided-platform-paves-way-for-more-precise-cancer-treatments/) - New ‘baited-SELEX’ technology merges small-molecule drug design with chemical biology to potentially improve treatment accuracy and reduce side effects. A collaborative team of researchers from the Department of Chemistry at the University of British Columbia (UBC) and the Vancouver Prostate Centre (VPC) have developed a new method to design safer, more targeted cancer drugs. The
- [Dr. Alexander Wyatt appointed UBC President’s Excellence Chair in Precision Oncology](https://mius.ca/dr-alexander-wyatt-appointed-ubc-presidents-excellence-chair-in-precision-oncology/) - Dr. Wyatt will advance precision cancer diagnostics and treatments for people across B.C. and globally. Dr. Alexander Wyatt, UBC President’s Excellence Chair in Precision Oncology The Faculty of Medicine is pleased to announce that Dr. Alexander Wyatt, a leading cancer genomics researcher, has been appointed the UBC President’s Excellence Chair in Precision Oncology. Dr. Wyatt
- [Introducing Mohseni Institute of Urologic Sciences](https://mius.ca/introducing-mohseni-institute-of-urologic-sciences/) - The M. H. Mohseni Institute of Urologic Sciences launches with $65M to advance urologic research and care across five new centres dedicated to innovation.
- [A Night of Generosity and Impact](https://mius.ca/a-night-of-generosity-and-impact/) - On June 28, James Killam hosted an extraordinary Century Tasting and dinner at his home in support of Dr. Y.Z. Wang’s research. Guests were treated to a rare and memorable tasting experience, featuring wines from every decade of the past century, paired with seasonal, organic dishes crafted by acclaimed chef and Top Chef Canada winner,
- [Dr. Nappi Discusses Post-Chemotherapy Residual Disease in Metastatic Testicular Cancer](https://mius.ca/dr-nappi-discusses-post-chemotherapy-residual-disease-in-metastatic-testicular-cancer/) - Dr. Lucia Nappi discusses managing post-chemo residual disease in metastatic testicular cancer, highlighting imaging, biomarkers, and surgical decision-making.
- [Dr. Ryan Flannigan Develop 3D Testicular Model to Study Unexplained Male Infertility](https://mius.ca/dr-ryan-flannigan-develop-3d-testicular-model-to-study-unexplained-male-infertility/) - A new study led by Dr. Ryan Flannigan, Director and urologist at the Reproductive & Sexual Medicine Centre (MIUS), is drawing national attention for its focus on unexplained male infertility. Highlighted by CBC News, Dr. Flannigan and his team have developed a lab-grown 3D model of human testes using stem cells. This breakthrough allows researchers
- [Break Wave Technology Offers Promising New Approach to Kidney Stone Treatment](https://mius.ca/break-wave-technology-offers-promising-new-approach-to-kidney-stone-treatment/) - Break Wave Lithotripsy offers a portable, non-invasive kidney stone treatment—showing strong results without sedation or hospital-based equipment.
- [New Research Reveals How Prostate Cancer Becomes More Aggressive — and How to Reverse It](https://mius.ca/new-research-reveals-how-prostate-cancer-becomes-more-aggressive-and-how-to-reverse-it/) - A new study led by Drs. Christopher Ong and Yuzhuo Wang has uncovered a key mechanism behind how prostate cancer transforms into a more dangerous form known as neuroendocrine prostate cancer (NEPC). This change, often triggered by standard hormone therapies, makes the disease more resistant to treatment. The research team discovered a signalling cascade in
- [Advancing Healthcare Innovation: VCHRI, MIUS & UBC](https://mius.ca/advancing-health-care-innovation-vchri-mius-ubc/) - VCHRI, MIUS & UBC drive healthcare innovation in BC through impactful research. Watch Dr. Gleave in the VCHRI Impact Video Series.
- [19th Annual Lorne D. Sullivan Lectureship & Research Day](https://mius.ca/19th-annual-lorne-d-sullivan-lectureship-research-day/) - We’re pleased to welcome Dr. Ganesh Pallapattu as the guest speaker for the 19th Annual Lorne D. Sullivan Lectureship and Research Day! Access the full program and abstracts here: 2025 – 19th Annual Lorne D. Sullivan Lectureship and Research Day Program (PDF).
- [Appointment of Dr. Martin Gleave as Chief Scientific Officer, M. H. Mohseni Institute of Urologic Sciences](https://mius.ca/appointment-of-dr-martin-gleave-as-chief-scientific-officer-m-h-mohseni-institute-of-urologic-sciences/) - We are delighted to announce the appointment of Dr. Martin Gleave as the inaugural Chief Scientific Officer of the M. H. Mohseni Institute of Urologic Sciences, for a five-year term to December 5, 2029. Dr. Gleave is a distinguished professor and chair of the Department of Urologic Sciences at the University of British Columbia (UBC)

## Pages

- [Home](https://mius.ca/) - Dedicated to advancing urologic research and care, the M. H. Mohseni Institute of Urologic Sciences leads innovation through science, collaboration, and impact.
- [Executive Team](https://mius.ca/about/executive-team/) - Meet the MIUS Executive Team—visionary leaders advancing urologic research, innovation, and patient care at the M. H. Mohseni Institute of Urologic Sciences
- [Dr Martin Gleave](https://mius.ca/about/executive-team/dr-martin-gleave-2/) - Home/About/Executive Team/Dr Martin GleaveDr. Martin GleavePositions: Chief Executive Officer, PC-TRiADD Distinguished Professor and Head, Department of Urologic Sciences, UBC BC Leadership Chair in Prostate Cancer Research Degrees: Doctor of Medicine, University of British Columbia Fellow of the Royal College of Surgeons of Canada Fellow, American College of Surgeons Order of Canada Bio: Dr. Gleave is
- [Contact](https://mius.ca/contact/) - Contact MIUS to explore research collaborations, partnerships, or academic opportunities. Connect with our team at the forefront of urologic innovation.
- [Advanced Genomics & Computational Science Core](https://mius.ca/core-facilities/advanced-genomics-computational-science-core/) - Explore MIUS's Advanced Genomics & Computational Science Core, offering cutting-edge technologies and expertise for innovative research.
- [Careers](https://mius.ca/careers/) - Explore careers at MIUS and help advance urologic research and care. Join a team making real-world impact in science, innovation, and patient outcomes.
- [Partners](https://mius.ca/about/partners/) - Discover the strategic partners collaborating with MIUS to drive urologic innovation, research excellence, and global health impact.
- [Donate](https://mius.ca/donate/) - Your donation fuels groundbreaking urologic research & advanced patient care at the M.H. Mohseni Institute of Urologic Sciences. Help transform lives in BC & worldwide.
- [Centre for Adolescent and Transitional Urology](https://mius.ca/the-centres/centre-for-adolescent-and-transitional-urology/) - Explore MIUS's Centre for Adolescent & Transitional Urology, providing specialized care for youth transitioning from pediatric to adult urologic services.
- [Centre for Kidney Stones & Minimally Invasive Surgery](https://mius.ca/the-centres/centre-for-kidney-stones-minimally-invasive-surgery/) - Explore the M.H. Mohseni Institute of Urologic Sciences, Centre for Kidney Stones, offering advanced minimally invasive kidney stone management and treatments.
- [The Reproductive & Sexual Medicine Centre](https://mius.ca/the-centres/the-reproductive-sexual-medicine-centre/) - Explore the Reproductive & Sexual Medicine Centre at MIUS, offering comprehensive care and research in reproductive and sexual health.
- [Centre for Kidney Transplantation and Immunology](https://mius.ca/the-centres/centre-for-kidney-transplantation-and-immunology/) - Explore MIUS's Centre for Kidney Transplantation & Immunology, advancing transplant care through innovative research and personalized immunological therapies.
- [Centre for Functional Urology and Reconstructive Surgery](https://mius.ca/the-centres/centre-for-functional-urology-and-reconstructive-surgery/) - Explore MIUS's Centre for Functional Urology & Reconstructive Surgery, offering advanced treatments for urinary disorders and reconstructive needs.
- [Vancouver Prostate Centre & the Centre for Urologic Oncology](https://mius.ca/the-centres/vancouver-prostate-centre-the-centre-for-urologic-oncology/) - Explore the Vancouver Prostate Centre at MIUS, advancing research and care in prostate and urologic cancers through innovation and collaboration.
- [Disease Modeling Core](https://mius.ca/core-facilities/disease-modeling-core/) - Explore MIUS's Disease Modeling Core, offering advanced models and technologies for translational research in disease mechanisms and therapeutics.
- [About](https://mius.ca/about/) - Discover how the M.H. Mohseni Institute is transforming urologic care through research, innovation, and global collaboration. Learn about our research.
- [Pulsed Photothermal Therapy: A Smart Weapon Against Cancer](https://mius.ca/pulsed-photothermal-therapy-a-smart-weapon-against-cancer/) - Highlighted Areas of ResearchPulsed Photothermal Therapy: A Smart Weapon Against CancerUsing Precision Heat to Kill Tumors and Supercharge the Immune System.Imagine a treatment that targets and destroys cancer cells with precision—without invasive surgery, radiation, or the toxic side effects of chemotherapy. A therapy that not only eliminates tumors but also boosts the body’s immune response,
- [Centres Leaders](https://mius.ca/about/centres-leaders/) - Learn more about the M.H. Mohseni Institute of Urological Sciences' core leaders driving innovation and excellence in urologic research & education.
- [Dr Larry Goldenberg](https://mius.ca/dr-larry-goldenberg/) - Dr. Larry GoldenbergPositions: Associate Director, Development and Supportive Care, Vancouver Prostate CentreProfessor, Department of Urologic Sciences, UBCStephen A. Jarislowsky Chair in Urologic Sciences at VGH Degrees: Doctor of Medicine, University of TorontoFellow of the Royal College of Surgeons of CanadaFellow, American College of SurgeonsFellow of the Canadian Academy of Health SciencesOrder of British ColumbiaOrder of
- [What Is MIUS?](https://mius.ca/what-is-mius/) - Learn what MIUS stands for and how the M. H. Mohseni Institute of Urologic Sciences is advancing urologic care through research, innovation, and collaboration.
- [Dr Alexander Wyatt](https://mius.ca/about/executive-team/dr-alexander-wyatt/) - Home/About/Executive Team/Dr Alexander WyattDr. Alexander WyattPositions: Associate Professor, Vancouver Prostate CentreScientist, Michael Smith Genome Sciences Centre, BC CancerAssociate Professor, Department of Urologic Sciences, University of British Columbia Degrees: B.Sc. (Biology), University of NottinghamD.Phil. (Physiology, Anatomy and Genetics), University of Oxford Bio: Dr. Wyatt is an Associate Professor in Urologic Sciences at the University of British
- [Dr Yuzhuo Wang](https://mius.ca/about/executive-team/dr-yuzhuo-wang/) - Home/About/Executive Team/Dr Yuzhuo WangDr. Yuzhuo WangPositions: Senior Research Scientist, Vancouver Prostate CentreHead of Molecular Pathology and Cell Imaging CoreAssociate Professor, Department of Urologic Sciences, University of British Columbia Degrees: BSc, MSc: Nankai University, Tianjin, ChinaPhD: The University of Hong Kong, Hong KongPost-doctoral Fellow: University of California, San Francisco (UCSF), USAFellow of the Canadian Academy of
- [Dr Ryan Flannigan](https://mius.ca/about/executive-team/dr-ryan-flannigan/) - Home/About/Executive Team/Dr Ryan FlanniganDr. Ryan FlanniganPositions: Director of Reproduction & Sexual Medicine Centre Associate Professor, Department of Urologic Sciences, University of British Columbia Senior Research Scientist, M.H. Mohseni Institute of Urologic Sciences Clinical Lead, Sexual Health Clinic, Prostate Supportive Care Program Fellowship Director, Male Infertility, Sexual Medicine & Microsurgery Program, Department of Urologic Sciences, University
- [Dr Ben Chew](https://mius.ca/about/executive-team/dr-ben-chew/) - Home/About/Executive Team/Dr Ben ChewDr. Ben ChewPositions: Director of Clinical Research Associate Professor, Department of Urologic Sciences, UBC Active Staff, Vancouver General Hospital Degrees: B.Sc.(H) Life Sciences, Queen’s University, 1992 M.Sc. Physiology, Queen’s University, 1994 M.D. University of British Columbia, 1998 Fellow of the Royal College of Surgeons of Canada (FRCSC), 2003 Fellow, Urology (Endourology &
- [Dr Amina Zoubeidi](https://mius.ca/about/executive-team/dr-amina-zoubeidi-4/) - Home/About/Executive Team/Dr Amina ZoubeidiDr. Amina ZoubeidiPositions: Professor, Department of Urologic Sciences, University of British Columbia Senior Research Scientist, Vancouver Prostate Centre Canada Research Chair in Cancer Therapy Resistance Degrees: B.Sc. University Mohamed V, Rabat, Morocco M.Sc. Université du Québec a Montréal Ph.D. Université de Montréal Post-Doc. McGill University Post-Doc. The Vancouver Prostate Centre
- [Dr Peter Black](https://mius.ca/about/executive-team/dr-peter-black/) - Home/About/Executive Team/Dr Peter BlackDr. Peter BlackPositions: Director, Vancouver Prostate Centre Senior Research Scientist, Vancouver Prostate Centre Associate Director, Clinical Research, Vancouver Prostate Centre Professor, Department of Urologic Sciences, University of British Columbia Khosrowshahi Family Chair Degrees: B.Sc. University of British ColumbiaM.D. Johannes Gutenberg University, Mainz, GermanyUrology Residency, University of Washington, Seattle, WAUrologic Oncology Fellowship, M.D.
- [The Centres](https://mius.ca/the-centres/) - Discover the M. H. Mohseni Institute of Urologic Sciences 6 leading urology research centres. Pioneering breakthroughs in cancer, transplantation, and beyond.
- [Dr Kate Anderson](https://mius.ca/about/executive-team/dr-kate-anderson/) - Home/About/Executive Team/Dr Kate AndersonDr. Kate AndersonPositions: Director, Functional Urology and Reconstructive Surgery Co-Director, The Centre for Adolescent and Transitional Urology Clinical Assistant Professor, Department of Urologic Sciences, UBC Co-Clinical Director, UBC Bladder Care Centre Diamond Family Surgeon-Scientist in Female and Functional Urology Degrees: Bachelor of Science, Biology, Acadia University Doctor of Medicine, Dalhousie University Fellow
- [Sustained Therapeutics Begins Cancer Trial](https://mius.ca/sustained-therapeutics-begins-cancer-trial/) - Highlighted Areas of ResearchSustained Therapeutics Begins Innovative Cancer TrialFor thousands diagnosed each year with Upper Tract Urothelial Carcinoma (UTUC), treatment options remain limited. This rare and complex cancer, affecting the kidney’s inner lining and the ureter, presents a unique challenge—its location makes complete removal difficult. But now, a new approach is bringing hope. Sustained Therapeutics,
- [Learning Centre: Your Kidneys](https://mius.ca/learning-your-kidneys/) - Home/Learning Centre: Your KidneysWhat You Need to Know: A Patient’s Journey Through Kidney Stone DiseaseInsights from Vancouver Coastal Health Research Institute Expert, Dr. Connor ForbesIt often starts with a sharp, unrelenting pain—sometimes so intense that it sends people straight to the emergency room. Each year, more than half a million individuals find themselves in this
- [Clinical Trials Core](https://mius.ca/core-facilities/clinical-trials-core/) - Advancing clinical research at M.H. Mohseni Urology Institute of Urological Sciences with expert trial design, data management, and regulatory support.
- [Advisory Board](https://mius.ca/about/advisory-board/) - Meet the MIUS Advisory Board—leading experts guiding innovation, research, and strategy at the M. H. Mohseni Institute of Urologic Sciences.
- [Research & Innovations](https://mius.ca/research-innovations/) - Discover the cutting-edge urologic research and medical device innovations at the M.H. Mohseni Institute. Learn about sustained therapies, diagnostics & more.
- [Core Facilities](https://mius.ca/core-facilities/) - Explore the cutting-edge research cores at the M.H. Mohseni Institute of Urologic Sciences: genomics, trials, imaging, modeling & therapeutics driving breakthroughs.
- [Core Leaders](https://mius.ca/about/core-leaders/) - Discover the dedicated leaders of MIUS Core Facilities driving innovation and excellence in urologic research and education.
- [Therapeutics Development Core](https://mius.ca/core-facilities/therapeutics-development-core/) - Therapeutics Development CoreTransforming drug discovery, the M.H. Mohseni Urology Institute of Urological Sciences’ Therapeutics Development core combines advanced computational tools, experimental pharmacology, and cutting-edge facilities to identify, refine, and validate novel therapeutics. Partner with us for unparalleled expertise and a streamlined path from target identification to clinical trials. Home/Core Facilities/Therapeutics Development CoreOverviewThe M.H. Mohseni Urology
- [Pathology and Cellular Imaging Core](https://mius.ca/core-facilities/pathology-and-cellular-imaging-core/) - Pathology and Cellular Imaging CoreThe M.H. Mohseni Urology Institute of Urological Sciences accelerates cancer research with advanced molecular analysis, cutting-edge imaging, and a comprehensive tumor bio-repository. Home/Core Facilities/Pathology and Cellular Imaging CorePathology and Cellular Imaging Core The M.H. Mohseni Urology Institute of Urological Sciences’ Molecular Pathology core facility offers clinical grade, high throughput analytical services
- [Dr Thomas de los Reyes](https://mius.ca/about/centres-leaders/dr-thomas-de-los-reyes/) - Home/About/Centres Leaders/Dr Thomas de los ReyesDr. Thomas De los ReyesPositions: Clinical Assistant ProfessorDepartment of Urologic Sciences | University of British ColumbiaCo-Director – Ledcor Centre for Adolescent and Transitional Urology | M.H. Mohseni Institute of Urologic SciencesPediatric Urologist, BC Children’s Hospital Bio: Dr. Thomas de los Reyes is a graduate of University of British Columbia’s faculty
- [Dr Mads Daugaard](https://mius.ca/about/executive-team/dr-mads-daugaard/) - Home/About/Executive Team/Dr Mads DaugaardDr. Mads DaugaardPositions: Senior Research Scientist, Vancouver Prostate CentreHead of Molecular Pathology and Cell Imaging CoreAssociate Professor, Department of Urologic Sciences, University of British Columbia Degrees: B.Sc. Biology, University of Copenhagen, Denmark M.Sc. Molecular Biology and Biochemistry, University of CopenhagenPh.D. Molecular Cancer Biology and Pathology, University of Copenhagen Bio: Dr. Mads Daugaard is
- [Dr Christopher Nguan](https://mius.ca/about/executive-team/christopher-nguan-md/) - Home/About/Executive Team/Dr Christopher NguanDr. Christopher NguanPositions: Surgical Director, Kidney Transplantation VGHAssociate Professor, UBC Department of Urologic SurgeryProgram Director, UBC Urology Postgraduate Training ProgramResearch Scientist, Vancouver Prostate CenterChair, Kidney Surgical Subcommittee, Canadian Blood Services Degrees: HBSc Microbiology & Immunology, Dalhousie UniversityMD Dalhousie UniversityUrology Residency, UBC UrologyMIS/Robotic & Multiorgan Transplantation Fellowship, University of Western Ontario Bio: Dr.
- [Dr Colin Collins](https://mius.ca/dr-colin-collins-2/) - Dr. Colin CollinsPositions: Senior Research Scientist, Vancouver Prostate Centre Head, Laboratory for Advanced Genome Analysis, Vancouver Prostate Centre Professor, Department of Urologic Sciences, University of British Columbia Degrees: B.Sc. Biological Sciences, Western New England College, MA, 1982 Cert. Genetics Engineering, San Francisco State University, CA, 1985 Ph.D. Medical Genetics, UBC, 1993 Bio: Dr Collins is

## Categories

- [News](https://mius.ca/category/news/uncategorized/)
- [News](https://mius.ca/category/news/)
- [Events](https://mius.ca/category/events/)

## Tags

- [News](https://mius.ca/tag/news/)
- [AZNUP](https://mius.ca/tag/aznup/)
- [AlexWyatt](https://mius.ca/tag/alexwyatt/)
- [Clonal Hematopoiesis](https://mius.ca/tag/clonal-hematopoiesis/)